Altcoins like Solana (SOL) have come to be recognized for their ability to remain resilient even when the market turns south. Following the FTX implosion, SOL tumbled to $8 giving savvy investors a chance to buy the heavily discounted crypto gem which recently topped $210 before correcting to $162. At the time of writing, Solana had recovered to $180. If investors desire such gains, they may want to get into the top 3 Solana rivals that could quickly flip a $10 portfolio into $1,000 including Dogecoin (DOGE), Injective (INJ), and Bitcoin Cash (BCH).

1. Dogecoin (DOGE) Tops Key Solana Rivals

The meme coin Dogecoin has impressively bounced back alongside a broader rally in the cryptocurrency sector, indicating a resurgence of investor trust in digital assets. Bitcoin has soared past the $66,000 mark, while Ethereum has climbed above $35,000, demonstrating widespread market enthusiasm.

After more than a year of stable trading, Dogecoin broke through the $0.1 barrier, reaching peaks above $0.2. Following this, the price encountered a bearish phase, confining it to a tight zone around $0.15. Nevertheless, the current positive momentum in the market suggests Dogecoin is on the verge of a significant upswing.

Dogecoin (DOGE) Price

Dogecoin has recently witnessed a significant boost in trading volume, escalating by 30% to hit $3.12 billion. Now ranked 9th in terms of market capitalization, its valuation stands at a robust $22.4 billion. This prominent position in the crypto market, especially during a bullish phase, suggests potential for further expansion.

2. Injective (INJ)

Injective (INJ) is making waves in the finance world with its pioneering, transparent, and interoperable first-layer blockchain. This platform is leading the charge in fostering a new wave of DeFi applications. Its offerings span decentralized exchanges for spot and derivatives trading, markets for predictions, and lending protocols.

Injective price chart

The platform’s native currency, INJ, is experiencing impressive growth, spurred by its novel features and expanding ecosystem. Presently, the Injective price is at $38.54, marking a 5.65% rise on the last day. It currently holds the 37th spot on CoinMarketCap, boasting a live market cap of $3.5 billion.

3. Bitcoin Cash (BCH)

The rally in Q4 prepared Bitcoin Cash for a bigger rally in Q1 which blasted the coin to new yearly highs at $530. However, the bullish theory took a temporary dive at the beginning of March as investors pocketed early profits.

BCH found relief from this temporary dive at $350 although a candle wick extended to $340 as shown on the four-hour chart.

Due to positive sentiment in the market and bolstered by Bitcoin’s surge to a new all-time high above $73,000, Bitcoin Cash aggressively bounced back, but this time it only made up to $450 before last week’s headwinds interfered culminating in another spiral drop to the $350 mark.

Bitcoin Cash (BCH) price chart | Tradingview

That said investors searching for key entry positions can consider buying BCH after the ongoing correction at $421 finds credible support. The previous day’s open value of $410 and the wedge pattern’s upper trendline would pass as key entry positions to consider when buying Bitcoin Cash.

The post Top 3 Solana Rivals On The Verge Of Turning $10 To $1000 appeared first on CoinGape.

---

Filed under: News - @ January 1, 1970 12:00 am